ONCODESIGN PRECISION MEDICINE

Highlights Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Market Closed - Euronext Paris Other stock markets 11:27:11 2024-05-22 am EDT			5-day change	1st Jan Change
1.24 ^EUR	-4.62%		-8.15%	-31.49%

May. 15	Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	CI
Jan. 25	Oncodesign Precision Medicine: fundraising on the horizon	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	May. 15	CI
Oncodesign Precision Medicine: fundraising on the horizon	Jan. 25	CF
Eurazeo acquires a stake in Oncodesign Services	Jan. 23	CF
Oncodesign Precision Medicine Société anonyme acquired Zobio B.v.	Jan. 22	CI
Oncodesign Precision Medicine Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers	23-10-02	CI
Oncodesign Precision Medicine Announces Initiation of Phase I of its RIPK2 Inhibitor ODS-101, aNew Therapeutic Agent for IBD	23-02-09	CI
Edmond de Rothschild Equity Strategies Management III S.à.r.l acquired 61.58% stakes in Oncodesign Precision Medicine Société anonyme from Philippe Genne and other managers and minority shareholder.	22-10-18	CI
Oncodesign Precision Medicine to List Directly on Euronext Access + Paris	22-10-05	MT
Oncodesign Société Anonyme completed the Spin-Off of Oncodesign Precision Medicine Société anonyme.	22-10-04	CI
Oncodesign Société Anonyme completed the Spin-Off of Oncodesign Precision Medicine Société anonyme.	22-10-04	CI
Oncodesign Société Anonyme agreed to Spin-Off Oncodesign Precision Medicine.	22-09-27	CI
Servier Exercises the Exclusive Worldwide License Option of Their Collaboration Program With Oncodesign Precision Medicine on Parkinson's disease	22-09-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW